Abstract
Many of the clinical and biological characteristics of tumor development appear to fit with the view that most neoplasms are unicellular in origin (i.e., ‘clones’) and that tumor progression results from ‘clonal evolution’, the sequential appearance within unstable neoplastic clones of subpopulations which are more and more genetically aberrant. These concepts, and the suggested underlying mechanisms, will be reviewed briefly, along with some of the supporting evidence. Although relatively few data are available from tumors occurring in the pediatric age group, some examples from both hematopoietic and nonhematopoietic neoplasms will be summarized. The findings support the general applicability of these concepts to pediatric neoplasms, but certain special characteristics of this age group require consideration, and these will be discussed from the standpoint of both their theoretical and practical implications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hamden D: The relationship between induced chromosome aberrations and chromosome abnormality in tumor cells. In Human Genetics, Armendares S, Lisker R (eds). Amsterdam: Excerpta Medica, 1977, pp 355–366.
Nowell P: Cytogenetics. In: Cancer: A Comprehensive Treatise, Vol I, Etiology, Becker F (ed). New York: Plenum, 1982, pp 3–46.
Fialkow P: Clonal origin of human tumors. Ann Rev Med 30: 135–143, 1979.
Heppner GH, Shapiro WR, Rankin JK: Tumor heterogeneity. In: Pediatric Oncology, Vol 1, Humphrey GB, Dehner LP, Grindey GB, Acton RT (eds). The Hague: Martinus Nijhoff, 1981, pp 99–116.
Linder D, Gartler SM: Glocuse-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas. Science 150: 67–69, 1965.
Friedman JM, Fialkow P: Viral tumorigenesis’ in man: cell markers in condylomata acuminata. Int J Cancer 17: 57–61, 1976.
Knudson AG: Mutation and cancer: statistical study of retinoblastoma. Proc Nat Acad Sci USA 68: 820–823, 1971.
Knudson A, Meadows A, Nichols W, Hill R: Chromosomal deletion and retinoblastoma. N Eng J Med 295: 1120–1123, 1976.
Cairns J: Mutation, selection, and the natural history of cancer. Nature 255: 197–200, 1975.
De Grouchy J, De Nava C: A chromosomal theory of carcinogenesis. Ann Int Med 69: 381–391, 1968.
Klein G: Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. Proc Natl Acad Sci USA 76: 2442–2446, 1979.
Makino S: Further evidence favoring the concept of the stem cell in ascites tumors of rats. Ann NY Acad Sci 64: 818–823, 1956.
Nowell P: The clonal evolution of tumor cell populations. Science 194: 23–28, 1976.
Rowley JD: Chromosome abnormalities in cancer. Cancer Genet and Cytogenet 2: 175–198, 1980.
Rowley JD: Ph-positive leukemia, including chronic myelogenous leukemia. Clinics in Haematol 9: 55–86, 1980.
Fialkow P, Denman A, Jacobson R, Leventhal M: Chronic leukemia: origin of some lymphocytes from leukemic stem cells. J Clin Invest 62: 815–822, 1978.
Nowell P, Finan J, Glover D, Guerry D: Cytogenetic evidence for the clonal nature of Richter’s syndrome. Blood 58: 183–186, 1981.
Mark J: Rous sarcoma in mice: the chromosomal progression in primary tumors. Eur J Cancer 5: 307–318, 1969.
Mitelman F: The chromosomes of fifty primary Rous rat sarcomas. Hereditas 69: 155–162, 1971.
Boveri T: In: Zur Frage der Entstehung maligner Tumoren. Jenai Gustav Fischer Verlag, 1914.
Von Hansemann D: Über asymmetrische Zellteilung in Epithelkrebsen and deren biologische Bedeutung. Virchow Arch Pathol Anat Physiol 119: 298–307, 1890.
Oksala T, Therman E: Mitotic abnormalities and cancer. In: Chromosomes and Cancer, German J (ed). New York: Wiley, 1974, pp 239–263.
Danes BS: Increased in vitrotetraploidy: tissue specific within the heritable colorectal cancer syndromes with polyposis coli. Cancer 41: 2330–2334, 1978.
Otter M, Palmer C, Baehner R: Elevated sister chromatid exchange rate in childhood lymphoblastic leukemia. Proc Am Assoc Cancer Res 19: 202, 1978.
Parshad R, Sanford KK, Tarone RE, Jones GM, Baeck AE: Increased susceptibility of mouse cells to fluorescent light-induced chromosome damage after long-term culture and malignant transformation. Cancer Res 39: 929–933, 1979.
Shiraishi Y, Sandberg AA: Effects of various chemical agents on sister chromatid exchanges, chromosome aberrations, and DNA repair in normal and abnormal human lymphoid cells. J Natl Cancer Inst 62: 27–33, 1979.
Sokova O, Volgareva G, Pogosiantz H: Effect of fluorafur on chromosomes of normal and malignant Djungarian hamster cells. Genetika 12: 156–159, 1976.
Weiner F, Dalianis T, Klein G, Harris H: Cytogenetic studies on the mechanism of formation of isoantigenic variants in somatic cell hybrids. J Natl Cancer Inst 52: 1779–1785, 1974.
German J: The association of chromosome instability, defective DNA repair, and cancer in some rare human genetic diseases. In: Human Genetics, Armendares S, Lisker R (eds). Amsterdam: Excerpta Medica, 1977, pp 64–68.
Hecht F, McCaw B: Chromosome instability syndromes. Prog Cancer Res Ther 3: 105–123, 1977.
Setlow R: Repair deficient human disorders and cancer. Nature 271: 713–717, 1978.
Li FP, Potter NU, Buchanan GR, Vawter G, Whang-Peng J, Rosen RB: A family with acute leukemia, hypoplastic anemia, and cerebellar ataxia: association with bone marrow C-monosomy. Am J Med 65: 933–939, 1978.
Nowell P: Preleukemia: cytogenetic clues in some confusing disorders. Am J Pathol 89: 459–476, 1977.
Seabright M: Patterns of induced aberrations in humans with abnormal autosomal complements. Chrom Today 5: 293–297, 1976.
Law IP, Hollinshead AC, Whang-Peng J, Dean JH, Oldham RK, Herberman RB, Rhode MC: Familial occurrence of colon and uterine carcinoma and of lymphoproliferative malignancies. Cancer 39: 1229–1236, 1977.
Miller OJ, Breg WR, Schmickel RD, Tretter W: A family with an XXXXY male, a leukemic male, and two 21 trisomie mongoloid females. Lancet ii: 78–79, 1961.
Heston L: Alzheimer’s disease, trisomy 21, and myeloproliferative disorders: associations suggesting a genetic diathesis. Science 196: 322–323, 1977.
Loeb L, Battula N, Springgate C, Seal G: On mutagenic DNA polymerase and malignancy. In: Fundamental Aspects of Malignancy. Berlin: Springer, 1975, pp 243–246.
Hecht F, Kaiser McCaw B: Position effects in 8; 14 translocation in Burkitt’s lymphoma. N Eng J Med 304: 174–175, 1981.
McClintock B: The origin and behavior of mutable loci in maize. Proc Natl Acad Sci USA 36: 344–355, 1950.
Sager R: Transposable elements and chromosomal rearrangements in cancer: a possible link. Nature 282: 447–448, 1979.
Biedler JL, Spengler BA: Metaphase chromosome anomaly: association with drug resistance and cell-specific products. Science 191: 185–187, 1976.
Balaban-Malenbaum G, Gilbert F: Double minute chromosomes and the homogeneously staining regions in chromosomes on a human neuroblastoma cell line. Science 198: 739–742, 1978.
Passarge E, Bartram C: Somatic recombination as possible prelude to malignant transformation. In: Birth Defects: Original Article Series. New York: The National Foundation, 1976, pp 177–180.
Turleau C, Cabanis MO, De Grouchy J: Augmentation des échanges de chromatides dans les fibroblasts d’un enfant atteint de del(13)-rétinoblastome. Annales de Génétique 23: 169170, 1980.
Cairns J: The origin of human cancers. Nature 289: 353–357, 1981.
Temin H: The DNA provirus hypothesis. Science 192: 1075–1080, 1976.
Whang-Peng J, Knutsen T, Ziegler J, Leventhal B: Cytogenetic studies in acute lymphocytic leukemia: special emphasis in long-term survival. Med Pediatr Oncol 2: 333–351, 1976.
Benedict W, Lange M, Greene J, Derencsenyi A, Alfi O: Correlation between prognosis and bone marrow chromosomal patterns in children with acute nonlymphocytic leukemia: similarities and differences compared to adults. Blood 54: 818–823, 1979.
Hecht F, McCaw B: Chromosome instability syndromes. Prog Cancer Res Ther 3: 105–123, 1977.
Levitt R, Pierre R, White W, Sickert R: Atypical lymphoid leukemia in ataxia-telangiectasia. Blood 52: 1003–1011, 1978.
Saxon A, Stevens R, Golde D: Helper and suppressor T-lymphocyte leukemia in ataxia telangiectasia. N Eng J Med 300: 700–704, 1979.
Nowell P, Shankey T, Finan J, Guerry D, Beas E: Proliferation, differentiation, and cytogenetics of chronic leukemic B lymphocytes cultured with motimycin-treated normal cells. Blood 57: 444–451, 1981.
Prindull G, Jentsch E, Hansmann I: Fanconi’s anaemia developing erythroleukemia. Scand J Haematol 23: 59–63, 1979.
Berenblum I: Sequential aspects of chemical carcinogenesis in skin. In: Cancer: A Comprehensive Treatise, Becker FF (ed). New York: Plenum Press, 1975, pp 323–344.
Farber E, Cameron C: The sequential analysis of cancer development. Adv Cancer Res 31: 125–225, 1980.
Orye E, Delbeke MJ: Clonal evolution in solid tumors in children. Oncol 29: 520–533, 1974.
Balaban-Malenbaum G, Gilbert F: The proposed origin of double minutes from homogeneously staining region (HSR) marker chromosomes in human neuroblastoma hybrid cell lines. Cancer Gen and Cytogen 2: 339–348, 1980.
Balaban-Malenbaum G, Gilbert F: unpublished.
Yunis JJ, Ramsay N: Retinoblastoma and subband deletion of chromosome 13. Am J Dis Child 132: 161–163, 1978.
Yunis JJ, Ramsay N: Retinoblastoma and subband deletion of chromosome 13. Am J Dis Child 132: 161–163, 1978.
Balaban-Malenbaum G, Gilbert F, Nichols W: Abnormalities in chromosome 13 in direct preparations from human retinoblastoma. Am J Human Gen 32: 62A, 1980.
Riccardi V, Sujansky E, Smith A, Francke U: Chromosomal imbalance in the aniridiaWilms’ tumor association: 11p interstitial deletion. Pediatrics 61: 604–610, 1978.
Braun AC: The Cancer Problem. New York: Columbia University Press, 1969.
Di Berardino MA, King TJ: Transplantation of nuclei from the frog renal adenocarcinoma. II. Chromosomal and histologic analysis of tumor nuclear transplant embryos. Develop Biol 11: 217–222, 1965.
Mintz B: Genetic mosaicism and in vivoanalyses of neoplasia and differentiation. Ann Symp Cancer Res 30: 27–53, 1978.
O’Hara M: Teratomas, neoplasia, and differentiation: a biological overview. I. The natural history of teratomas. Invest Cell Pathol 1: 39–63, 1978.
Kolber AR, Goldstein MN, Moore BW: Effect of nerve growth factor on the expression of colchicine–binding activity and 14–3–2 protein in an established line of human neuroblastoma. Proc Natl Acad Sci USA 71: 4203 – 4207, 1974.
Mintz B, Illmensee K: Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci USA 72: 3585–3589, 1975.
Meadows AT, Strong LC, Li SP, D’Angio DJ, Schweisguth O, Freeman AI, Jenkin RDT, Morris-Jones P, Nesbit ME: Bone sarcoma as a second malignant neoplasm in children: influence of radiation and genetic disposition. Cancer 46: 603–606, 1980.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Nowell, P.C., Balaban, G.B. (1982). Clonal Evolution and Childhood Tumors. In: Humphrey, G.B., Grindey, G.B., Dehner, L.P., Acton, R.T., Pysher, T.T. (eds) Pancreatic Tumors in Children. Cancer Treatment and Research, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7615-3_2
Download citation
DOI: https://doi.org/10.1007/978-94-009-7615-3_2
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-7617-7
Online ISBN: 978-94-009-7615-3
eBook Packages: Springer Book Archive